CSI Market
Sign In | Register

Unity Biotechnology Inc (UBX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access UBX Annual Balance Sheets →
Looking at balance sheet data from Unity Biotechnology Inc through Mar 31 2024 provides insight into Mar 31 2025's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent8.00
Marketable Securities, Current SH8.93
Cash & Short-term Investments15.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.71
Total Current Assets17.65
Equipment/Property/Plant Net3.28
Long-term investments0.00
Other Assets, Noncurrent9.42
Restricted Cash Noncurrent0.90
Total Assets30.35
Liabilities
Accounts Payable, Current AC1.76
Accrued Liabilities, Current AC6.06
Other Liabilities, Current1.24
Total Current Liabilities9.07
Total Long-term Debt0.00
Other liabilities, Noncurrent21.49
WarrantLiabilityNoncurrent2.81
Total Liabilities30.55
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock517.44
Retained Earnings / Accumulated Deficit-517.65
Other Equity0.00
Common Stockholder's Equity-0.21
Total Stockholder's Equity-0.21
Liabilities & Stockholder's Equity30.35
4 historic quarters locked

Sign in to unlock the full Unity Biotechnology Inc balance sheet history.

Sign In Create Free Account

About Unity Biotechnology Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250331)
  • Filed with the SEC: April 22, 2025
  • Source: ubx-20250331.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-056789

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.